Clinical Trial Update: Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and pharmacokinetics of Alpha-1 Proteinase Inhibitor in individuals with Alpha-1 antitrypsin deficiency completed, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Emphysema

Drugs mentioned

• Alpha-1 Proteinase Inhibitor

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Emphysema, Alpha 1-antitrypsin Deficiency (AATD) | Phase 2 | Status: COMPLETED | Results posted: 2013-05-20